HELX ISSUER
The issuer of HELX, the Health and Life Sciences AlphaDEX Fund, is known for its commitment to providing investors with exposure to companies in the health and life sciences sector. This ETF is designed to track the investment results of the Health and Life Sciences AlphaDEX Index, which selects and ranks stocks from the health and life sciences sector based on various fundamental factors. With a focus on innovation and advancements in healthcare and life sciences, the issuer aims to deliver a diversified and performance-driven investment opportunity to its shareholders.
HELX DIVIDEND
The ETF issuer for HELX Dividend, the Health and ESG Leaders ETF, is committed to providing investors with exposure to companies that meet specific environmental, social, and governance (ESG) criteria within the healthcare sector. While dividend distribution may not be the primary focus of this ETF, it still reflects the dividend policies and performances of the underlying healthcare companies it comprises. Dividend distributions from HELX are influenced by the dividend practices of these healthcare companies and are typically made on a regular basis, offering investors a potential source of income along with ESG-focused investment opportunities.
HELX TRACKING
Tracking innovative technology companies is the primary focus of the HELX ETF's investment strategy. This ETF aims to closely follow the performance of U.S. companies that utilize innovative technologies or ideas to gain a competitive edge over their peers. HELX predominantly invests in large-cap equities traded on U.S. stock exchanges, including common stocks, preferred stocks, ADRs, and securities from IPOs, with a notable allocation to the information technology sector. The fund employs a rigorous three-component investment process, incorporating macroeconomic analysis, fundamental research, and technical analysis to identify stocks with strong growth potential. HELX is an attractive option for investors seeking exposure to innovative technology-driven companies within the U.S. market.
HELX CORRELATION
Understanding the correlation dynamics of the HELX ETF is essential for investors seeking to gauge its performance in relation to various market conditions. HELX's correlation with specific asset classes and market indices can provide insights into its risk-return profile. ETF Insider's web app offers a powerful tool to study these correlations, offering in-depth data and visualizations that help investors make informed decisions. By analyzing how HELX correlates with other assets, investors can better assess its role in their portfolios and identify potential diversification opportunities.
HELX SECTOR
The Health and Life Sciences Innovation ETF (HELX) focuses on the rapidly evolving health and life sciences sector. This sector encompasses companies involved in groundbreaking medical research, pharmaceuticals, biotechnology, and healthcare services. HELX offers investors exposure to innovative advancements in healthcare and life sciences, making it an appealing choice for those seeking growth potential in this dynamic industry.
HELX EXPOSURE
The HELX ETF, or HealthTech Innovations Exposure ETF, focuses on offering investors exposure to the rapidly growing healthcare technology sector. This ETF is designed to track an index composed of companies involved in innovative healthcare technologies, including biotechnology, telemedicine, and digital health solutions. With the healthcare industry undergoing significant transformation driven by technological advancements, HELX provides a unique investment avenue for those seeking to participate in this dynamic and promising market segment.